Creatine May Build Muscle in Sedentary Adults, but Exercise Still Yields Greater Gains

Key points

• Sedentary participants in the trial gained about 2.4 pounds of lean tissue using DXA scans, despite not exercising.
• The study used a 10-gram daily dose, which is double the standard 5-gram maintenance recommendation.
• Creatine supports ATP regeneration in muscles, aiding short, high-intensity efforts rather than providing instant energy.
• Experts caution that creatine does not replace training; it merely enhances the capacity for additional repetitions or lifts.
• Safety is generally high for healthy adults, but those with kidney issues or pregnancy should consult a doctor.

Background

Previous coverage in August 2026 highlighted similar findings regarding creatine’s impact on memory and muscle mass in sedentary adults. This new analysis reinforces that while supplements can offer standalone benefits, they are most effective when paired with physical activity and proper nutrition.

How outlets are covering it

ZME Science and GQ focus on the novel finding that creatine can induce lean mass gains without exercise, highlighting the 1.1 kg increase in the Texas A&M trial. In contrast, Daily Maverick and UA.News emphasize the limitations of this approach, noting that creatine is not a magic bullet. South African experts cited in these outlets stress that while creatine helps with ATP regeneration, it cannot compensate for poor training or nutrition. They also point out that evidence for benefits beyond strength, such as bone density or neuroprotection, remains unproven, and that individual responses vary significantly.

Why it matters

This finding is significant for aging populations who may be unable to engage in structured exercise programs. It suggests that creatine supplementation could serve as a partial intervention to combat age-related muscle loss, though it should not be viewed as a replacement for physical activity.

What to watch

Researchers continue to investigate creatine’s role in cognitive health and cancer patient support, though current evidence for these areas remains limited. Future studies will likely focus on optimizing dosage for different demographics, including women and older adults, to better understand long-term safety and efficacy.